New drugs, diagnostics, and specialty clinics that treat mental illness, dry eye, and neurodegeneration using hormones, psychedelics, light-driven eye therapy, and gut-brain biomarkers.
New therapeutic & diagnostic modalities (mental health, ocular, gut‑brain)
Recent reporting shows clear openings: Peter Attia argues hormones matter in psychiatry, Hacker News highlights a photosynthetic approach to treating dry eye, and Wired links gut health with Alzheimer’s. That mix of evidence makes now a practical moment to commercialize hormone- and psychedelic-based psychiatric drugs and clinics, light-driven eye therapies, and gut‑brain diagnostics.
Projected Score
as a side gig ☆☆☆☆☆ (0/5)
no money or audience ☆☆☆☆☆ (0/5)
with both ★★★☆☆ (3/5)
Want this one researched? Commission the full dossier for $15: we research and write it, and you read it first. Then you choose — pay more to keep it exclusive, or do nothing and it goes public on this site. The score above is our forecast for a dossier we haven’t written yet.
The news behind it
- Aug 17, 2026 Peter Attia: #404 ‒ Mental health beyond neurotransmitters: the role of hormones in psychiatry, why symptom reduc
- Aug 17, 2026 Hacker News (Algolia): Applying a photosynthetic process to treat “dry eye”
- Aug 17, 2026 Wired: There’s a New Link Between Gut Health and Alzheimer’s Disease
